Overview
George Klein practices practicing medicine in Stockholm, Sweden.
His clinical expertise encompasses Mononucleosis, Retinoblastoma, B-Cell Lymphoma, and Burkitt Lymphoma.
He is actively involved in clinical research, co-authoring 29 peer reviewed articles.
Gender
Locations
Stockholm, AB 17165, Sweden
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about George Klein
Is George Klein a top-rated expert for Mononucleosis?
MediFind is an objective health platform that identifies experts based on real-world data. George Klein is classified as an Experienced expert for Mononucleosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does George Klein participate in research or clinical trials?
Yes. George Klein has published 29 articles and abstracts on conditions like Mononucleosis. You can view a list of George Klein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- B-Cell LymphomaMr. Klein isExperienced. Learn about B-Cell Lymphoma.
- Burkitt LymphomaMr. Klein isExperienced. Learn about Burkitt Lymphoma.
- MononucleosisMr. Klein isExperienced. Learn about Mononucleosis.
- RetinoblastomaMr. Klein isExperienced. Learn about Retinoblastoma.